Apoquel® contains oclacitinib, a Janus kinase (JAK) inhibitor that targets specific cytokines involved in the inflammatory and pruritic pathways. By inhibiting these cytokines, Apoquel® effectively reduces itching and inflammation in dogs suffering from allergic skin conditions. It offers rapid relief, often within 4 hours, and can be administered long-term under veterinary supervision.
| Indications | Control of pruritus associated with allergic dermatitis in dogs at least 12 months of age. Control of atopic dermatitis in dogs at least 12 months of age. |
|---|---|
| Contraindications | Not for use in dogs less than 12 months of age. Not recommended for dogs with serious infections. Use with caution in dogs with a history of neoplasia, as Apoquel® may exacerbate neoplastic conditions. |
| Dosage | Dosage for Dogs: Initial Therapy: Administer 0.4–0.6 mg/kg body weight, orally, twice daily for up to 14 days. Dosage for Cats: The safety and efficacy of Apoquel® in cats have not been established; therefore, its use in feline patients is not recommended. |
| Storage | Store at controlled room temperature, 20°C–25°C (68°F–77°F), with excursions permitted between 15°C–30°C (59°F–86°F). |
Be the first to review “Apoquel®”
Reviews
There are no reviews yet.